Adial Pharmaceuticals Inc

Financial Scores

A year in review: Adial Pharmaceuticals Inc (ADIL)’s performance in the last year

Arcelia Reed

While Adial Pharmaceuticals Inc has underperformed by -8.14%, investors are advised to look at stock chart patterns for technical insight. ...

Analyst Snapshot

ADIL’s Q2 earnings estimates: What investors need to know

Patricia Turner

Adial Pharmaceuticals Inc (ADIL)’s stock is trading at $0.31 at the moment marking a rise of 2.36% from the last ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.